Krishna Institute of Medical Sciences Ltd (BOM:543308)
₹ 793.6 -26.7 (-3.25%) Market Cap: 317.55 Bil Enterprise Value: 361.62 Bil PE Ratio: 131.95 PB Ratio: 14.13 GF Score: 85/100

Q1 2026 Krishna Institute of Medical Sciences Ltd Earnings Call Transcript

Aug 07, 2025 / 04:30AM GMT
Release Date Price: ₹743.65 (-0.97%)

Key Points

Positve
  • Krishna Institute of Medical Sciences Ltd (BOM:543308) reported a total revenue of INR 879 crore, marking a growth of 26.8% year-on-year and 9.6% quarter-on-quarter.
  • The company has expanded its operations significantly, with 25 centers across five states and a bed capacity of 8,000.
  • New units in Bangalore and Kerala have been launched, with promising initial responses and plans for further expansion.
  • The company is leveraging technology and AI to improve patient outcomes and operational efficiency.
  • Krishna Institute of Medical Sciences Ltd (BOM:543308) is focusing on expanding its oncology services, which is expected to enhance its service mix and revenue potential.
Negative
  • The company reported a decline in EBITDA margin to 22.7% from 26.6% in the previous year.
  • New units have contributed to losses, with a combined loss of INR 21 crore in Q1, expected to increase slightly in Q2.
  • The ramp-up at some new units, particularly in Nasik, has been slow due to delays in insurance tie-ups.
  • Occupancy and IP volume in the mature Telangana cluster remain range-bound, with limited growth potential.
  • Insurance empanelment for new hospitals is taking longer than expected, impacting patient volumes and revenue.
Operator

Ladies and gentlemen, good day, and welcome to the KIMS Hospital Q1 FY26 earnings conference call hosted by IIFL Capital Services Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Rahul Jeewani from IIFL Capital Services Limited. Thank you, and over to you, sir.

Rahul Jeewani
IIFL Finance Ltd - Analyst

Yeah, thank you, Shuti. Hi, good morning, everyone. This is Rahul from IIFL Capital. I welcome you all to the first quarter earnings conference call of KIMS Hospitals. From KIMS, we have with us today Dr. Bhaskara Bollineni, Founder and Managing Director; Dr. Abhinay Bollineni, Executive Director and CEO; and Mr. Sachin Salvi, CFO.

Over to you, sir, for your opening comments.

Bhaskara Bollineni
Krishna Institute of Medical Sciences Ltd - Executive Chairman of the Board, Managing Director

Greetings and a hearty welcome to you all.

Next week we are going to celebrate the 70th Independence Day. The air is full of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot